Skip to main content
Log in

Indobufen vs heparins for prophylaxis of postop complications

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Indobufen vs heparins for prophylaxis of postop complications. Pharmacoecon. Outcomes News 71, 5 (1996). https://doi.org/10.1007/BF03270147

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03270147

Keywords

Navigation